AEPCX
Price
$63.15
Change
+$0.82 (+1.32%)
Updated
Oct 20 closing price
Net Assets
137.06B
LAVGX
Price
$17.39
Change
+$0.22 (+1.28%)
Updated
Oct 20 closing price
Net Assets
3.83M
Interact to see
Advertisement

AEPCX vs LAVGX

Header iconAEPCX vs LAVGX Comparison
Open Charts AEPCX vs LAVGXBanner chart's image
American Funds EUPAC C
Price$63.15
Change+$0.82 (+1.32%)
VolumeN/A
Net Assets137.06B
Lord Abbett International Growth R6
Price$17.39
Change+$0.22 (+1.28%)
VolumeN/A
Net Assets3.83M
AEPCX vs LAVGX Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 137B vs. LAVGX (3.83M). LAVGX pays higher dividends than AEPCX: LAVGX (0.39) vs AEPCX (0.16). AEPCX was incepted earlier than LAVGX: AEPCX (25 years) vs LAVGX (4 years). LAVGX (9.10) is less costly to investors than AEPCX (1.57). LAVGX is a more actively managed with annual turnover of: 125.00 vs. AEPCX (35.00). LAVGX has a lower initial minimum investment than AEPCX: LAVGX (0) vs AEPCX (250). LAVGX annual gain was more profitable for investors over the last year : 18.04 vs. AEPCX (10.71).
AEPCXLAVGXAEPCX / LAVGX
Total Expense Ratio1.570.68231%
Annual Report Gross Expense Ratio1.579.1017%
Fund Existence25 years4 years-
Gain YTD22.21825.92386%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets137B3.83M3,577,023%
Annual Yield % from dividends0.160.3940%
Returns for 1 year10.7118.0459%
Returns for 3 years47.4074.4264%
Returns for 5 years10.94N/A-
Returns for 10 years36.39N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PLX2.140.28
+15.05%
Protalix BioTherapeutics
CLPT27.321.94
+7.67%
ClearPoint Neuro
XENE43.441.81
+4.35%
Xenon Pharmaceuticals
PSIG4.030.01
+0.25%
PS International Group Ltd.
PHM123.27-1.18
-0.95%
Pultegroup